(Q51741077)

11 April 2018

title

In vivo effects of mutant HERG K+ channel inhibition by disopyramide in patients with a short QT-1 syndrome: a pilot study. (English)

1 reference

11 April 2018

5

Martin Borggrefe

1 reference

11 April 2018

Rainer Schimpf

1

Rainer Schimpf

1 reference

11 April 2018

Christian Wolpert

6

Christian Wolpert

1 reference

11 April 2018

Christian Veltmann

2

Christian Veltmann

1 reference

11 April 2018

Carla Giustetto

3

Carla Giustetto

1 reference

11 April 2018

Fiorenzo Gaita

4

Fiorenzo Gaita

1 reference

11 April 2018

publication date

16 August 2007

1 reference

11 April 2018

Journal of Cardiovascular Electrophysiology

published in

1 reference

11 April 2018

volume

18

1 reference

11 April 2018

issue

11

1 reference

11 April 2018

page(s)

1157-1160

1 reference

11 April 2018

Short QT Syndrome: a familial cause of sudden death

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00925.X

Short QT syndrome: successful prevention of sudden cardiac death in an adolescent by implantable cardioverter-defibrillator treatment for primary prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00925.X

Congenital short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00925.X

Short QT syndrome: pharmacological treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00925.X

Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00925.X

Disopyramide is an effective inhibitor of mutant HERG K+ channels involved in variant 1 short QT syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00925.X

Disopyramide: although potentially life-threatening in the setting of long QT, could it be life-saving in short QT syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00925.X

An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00925.X

Modulation of transmural repolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00925.X

Excessive increase in QT interval and dispersion of repolarization predict recurrent ventricular tachyarrhythmia after amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00925.X

Sudden death associated with short-QT syndrome linked to mutations in HERG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00925.X

Modulation of I(Kr) inactivation by mutation N588K in KCNH2: a link to arrhythmogenesis in short QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00925.X

Comparison of the effect of class IA antiarrhythmic drugs on transmembrane potassium currents in rabbit ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00925.X

10.1111/J.1540-8167.2007.00925.X

21 January 2018

Identifiers

DOI

1 reference

11 April 2018

1 reference

11 April 2018